Wintrust Investments’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,790
Closed -$236K 482
2024
Q1
$236K Buy
+1,790
New +$224K 0.02% 418
2021
Q3
Sell
-1,326
Closed -$207K 416
2021
Q2
$207K Buy
1,326
+1
+0.1% +$162 0.02% 401
2021
Q1
$206K Sell
1,325
-828
-38% -$128K 0.02% 383
2020
Q4
$322K Sell
2,153
-31
-1% -$4.38K 0.09% 130
2020
Q3
$289K Buy
2,184
+196
+10% +$25.6K 0.04% 274
2020
Q2
$230K Buy
+1,988
New +$229K 0.03% 312

Other funds holding ZBH

Wintrust Investments's ZBH Position: Q2 2024 in Review

Wintrust Investments sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 1,790 shares — an estimated $236K sold.

Wintrust Investments first reported a position in ZBH in Q2 2020 and held it in 6 quarters. The position peaked at $322K in Q4 2020. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

  • Wintrust Investments reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
  • Wintrust Investments sold 1,790 Zimmer Biomet shares in Q2 2024, an estimated $236K.
  • Wintrust Investments first reported a position in Zimmer Biomet in Q2 2020 and held it in 6 quarters.
  • Wintrust Investments's Zimmer Biomet position peaked at $322K in Q4 2020.
  • 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on Wintrust Investments's 13F filing for Q2 2024, filed 13 Aug 2024.